Gangadhar Anirudh, Sari-Sarraf Hamed, Vanapalli Siva A
Department of Chemical Engineering, Texas Tech University Lubbock TX 79409 USA
Department of Electrical and Computer Engineering, Texas Tech University Lubbock TX 79409 USA.
RSC Adv. 2023 Feb 2;13(7):4222-4235. doi: 10.1039/d2ra07972k. eCollection 2023 Jan 31.
Currently, detection of circulating tumor cells (CTCs) in cancer patient blood samples relies on immunostaining, which does not provide access to live CTCs, limiting the breadth of CTC-based applications. Here, we take the first steps to address this limitation, by demonstrating staining-free enumeration of tumor cells spiked into lysed blood samples using digital holographic microscopy (DHM), microfluidics and machine learning (ML). A 3D-printed module for laser assembly was developed to simplify the optical set up for holographic imaging of cells flowing through a sheath-based microfluidic device. Computational reconstruction of the holograms was performed to localize the cells in 3D and obtain the plane of best focus images to train deep learning models. We developed a custom-designed light-weight shallow Network dubbed s-Net and compared its performance against off-the-shelf CNN models including ResNet-50. The accuracy, sensitivity and specificity of the s-Net model was found to be higher than the off-the-shelf ML models. By applying an optimized decision threshold to mixed samples prepared , the false positive rate was reduced from 1 × 10 to 2.77 × 10. Finally, the developed DHM-ML framework was successfully applied to enumerate spiked MCF-7 breast cancer cells and SkOV3 ovarian cancer cells from lysed blood samples containing white blood cells (WBCs) at concentrations typical of label-free enrichment techniques. We conclude by discussing the advances that need to be made to translate the DHM-ML approach to staining-free enumeration of actual CTCs in cancer patient blood samples.
目前,癌症患者血液样本中循环肿瘤细胞(CTC)的检测依赖于免疫染色,这种方法无法获取活的CTC,限制了基于CTC的应用范围。在此,我们迈出了解决这一限制的第一步,通过使用数字全息显微镜(DHM)、微流控技术和机器学习(ML),展示了对添加到裂解血液样本中的肿瘤细胞进行无染色计数。开发了一个用于激光组装的3D打印模块,以简化对流经基于鞘流的微流控装置的细胞进行全息成像的光学设置。对全息图进行计算重建,以便在三维空间中定位细胞,并获得最佳聚焦平面图像来训练深度学习模型。我们开发了一个定制设计的轻量级浅层网络,称为s-Net,并将其性能与包括ResNet-50在内的现成CNN模型进行了比较。发现s-Net模型的准确性、敏感性和特异性高于现成的ML模型。通过对制备的混合样本应用优化的决策阈值,假阳性率从1×10降至2.77×10。最后,所开发的DHM-ML框架成功应用于对来自含有白细胞(WBC)的裂解血液样本中的添加的MCF-7乳腺癌细胞和SkOV3卵巢癌细胞进行计数,这些样本的浓度为无标记富集技术的典型浓度。我们通过讨论将DHM-ML方法转化为对癌症患者血液样本中实际CTC进行无染色计数所需的进展来得出结论。